Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709409 | PMC |
| http://dx.doi.org/10.3389/fgene.2015.00364 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns.
Clin Infect Dis
August 2023
Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.
When the Whole Is the Sum of Its Parts: Validation of the Heart Failure Collaboratory Medication Composite Score in Denmark.
Circ Heart Fail
February 2023
Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (L.A.A.).
Reply letter to the editor concerning the article 'Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance'.
Hum Vaccin Immunother
November 2022
Pharmacy Department, Infanta LeonorUniversity Hospital, Madrid, Spain.
According to the current European medicines legislation, on the labeling is mandatory a warning contraindicating for hereditary fructose intolerance (HFI) patients medicines with oral or parenteral fructose and sorbitol, and oral sucrose, invert sugar, isomaltitol, lactitol and maltitol, but parenteral sucrose is not mentioned. Intravenous administration of sucrose does not increase blood glucose concentrations, because sucrose is poorly oxidized to CO and mainly excreted in the urine as a disaccharide; absence of enzimatic activity outside the gut explains why there is not a warning for parenteral sucrose presentations. For this reason, parenteral drugs with sucrose are allowed in HFI patients.
View Article and Find Full Text PDFReply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance".
Hum Vaccin Immunother
November 2021
Paediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Paediatrics, University Clinical Hospital, Santiago de Compostela, Spain.
In the letter, Urro et al. performed a search on the sucrose, fructose and sorbitol content in the approved Sars-Cov-2 vaccines and they concluded that these vaccines can be safely administered in adults affected by Hereditary fructose intolerance.The Pfizer-BioNTech COVID-19 Vaccine is currently approved for use in adolescents ≥ 12 years and the Moderna COVID-19 vaccine is close to approval for use in children over 12 years of age.
View Article and Find Full Text PDFLicogliflozin effective in PCOS treatment.
Nat Rev Endocrinol
October 2021
Nature Reviews Endocrinology, .
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!